| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8792467 | Journal of American Association for Pediatric Ophthalmology and Strabismus | 2017 | 8 Pages |
Abstract
We report the case of a premature infant with end-organ failure who developed high-risk retinopathy of prematurity (ROP) bilaterally and was treated with intravitreal bevacizumab (IVB) injection therapy with regression noted on follow-up clinical examination. The infant died 3Â weeks after IVB injection therapy. Histopathological analysis was conducted on bilateral globes and revealed persistent preretinal vessels.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Carson R. MD, Christopher K.H. MD, Heather A.D. MD, Devasis MD, Kenneth B. MD, Deborah M. MS, MD,